Veracyte (VCYT) Tops Q2 EPS by 9c

Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.13), $0.09 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $72.9 million versus the consensus estimate of $68.08 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Investing.com’s stocks of the week